Virtu Financial LLC Cytosorbents Corp Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$1.08 - $1.94 $21,832 - $39,217	20,215 New	20,215 $22,000
Q1 2022 May 17, 2022	SELL	$2.88 - $4.23 $31,386 - $46,098	-10,898 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.05 - $8.11 $44,136 - $88,382	10,898 New	10,898 $46,000
Q1 2019 Apr 12, 2019	SELL	$6.82 - $8.56 $77,604 - $97,404	-11,379 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$7.05 - $12.64 $16,595 - $29,754	-2,354 Reduced 17.14%	11,379 $92,000

Q1 2018 May 14, 2018	BUY	$6.55 - $8.2 $89,951 - $112,610	13,733 New	13,733 $97,000
Q4 2017 Feb 09, 2018	SELL	$5.9 - $7.05 $320,712 - $383,223	-54,358 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.5 - $6.2 $244,611 - $337,019	54,358	54,358 $0

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.